(Q39839500)

15 September 2017

Transfer of Her-2/neu specificity into cytokine-induced killer (CIK) cells with RNA encoding chimeric immune receptor (CIR). (English)

1 reference

15 September 2017

Sung Hee Yoon

1

1 reference

15 September 2017

Jin Myung Lee

2

1 reference

15 September 2017

Sun-Je Woo

3

1 reference

15 September 2017

Min-Ji Park

4

1 reference

15 September 2017

Jung-Sun Park

5

1 reference

15 September 2017

Hye-Sung Kim

6

1 reference

15 September 2017

Mi-Young Park

7

1 reference

15 September 2017

Hyun-Jung Sohn

8

1 reference

15 September 2017

Tai-Gyu Kim

9

1 reference

15 September 2017

language of work or name

1 reference

11 June 2009

1 reference

Journal of Clinical Immunology

15 September 2017

1 reference

15 September 2017

29

1 reference

15 September 2017

6

1 reference

15 September 2017

806-814

1 reference

https://scigraph.springernature.com/pub.10.1007/s10875-009-9308-6

15 September 2017

0 references

cites work

Cytokine-induced killer cells targeted by the novel bispecific antibody CD19xCD5 (HD37xT5.16) efficiently lyse B-lymphoma cells

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-009-9308-6

Characterization of in vitro migratory properties of anti-CD19 chimeric receptor-redirected CIK cells for their potential use in B-ALL immunotherapy.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-009-9308-6

Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10875-009-9308-6

Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients.

21 January 2018

1 reference

12 December 2020

Genetic manipulation of telomerase in HIV-specific CD8+ T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization

1 reference

12 December 2020

Efficient genetic modification of murine dendritic cells by electroporation with mRNA

1 reference

12 December 2020

Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells

1 reference

12 December 2020

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

12 December 2020

ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency

1 reference

12 December 2020

CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.

1 reference

12 December 2020

Clinical trials of Herceptin(R) (trastuzumab)

1 reference

12 December 2020

Optimizing adoptive polyclonal T cell immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 and CD137 costimulatory domains

1 reference

12 December 2020

Receptor blockade with monoclonal antibodies as anti-cancer therapy

1 reference

12 December 2020

RAET1E2, a soluble isoform of the UL16-binding protein RAET1E produced by tumor cells, inhibits NKG2D-mediated NK cytotoxicity

1 reference

12 December 2020

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity

1 reference

12 December 2020

Monoclonal antibodies in therapy of solid tumors

1 reference

12 December 2020

Replicative potential of human natural killer cells

1 reference

12 December 2020

High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation

1 reference

12 December 2020

Adoptive immunotherapy using human peripheral blood lymphocytes transferred with RNA encoding Her-2/neu-specific chimeric immune receptor in ovarian cancer xenograft model

1 reference

12 December 2020

Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study

1 reference

12 December 2020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

12 December 2020

Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytes

1 reference

12 December 2020

IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes

1 reference

12 December 2020

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

12 December 2020

Genotoxicity of retroviral integration in hematopoietic cells.

1 reference

12 December 2020

Gene therapy. Safer and virus-free?

1 reference

12 December 2020

Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphoma

1 reference

12 December 2020

Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

1 reference

12 December 2020

HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells

1 reference

12 December 2020

Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene

1 reference

12 December 2020

Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors.

1 reference

12 December 2020

10.1007/S10875-009-9308-6

Identifiers

DOI

1 reference

15 September 2017

1 reference